Comprehensive Analysis of Serum and Fecal Bile Acid Profiles and Interaction with Gut Microbiota in Primary Biliary Cholangitis

Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism

Wahlstrom, A. M., Sayin, S. I., Marschall, H., & Bäckhed, F. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.005 · Cited by 2,903 · see citing works

Bile salt biotransformations by human intestinal bacteria

Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r500013-jlr200 · Cited by 2,829 · see citing works

The Enzymes, Regulation, and Genetics of Bile Acid Synthesis

Russell, D. W. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161712 · Cited by 2,069 · see citing works

Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice

Devkota, S., Wang, Y., Musch, M. W., Leone, V., Fehlner-Peach, H., Nadimpalli, A., Antonopoulos, D. A., Jabri, B., & Chang, E. B. (2012) · Nature · doi:10.1038/nature11225 · Cited by 1,904 · see citing works

Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis

Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.001 · Cited by 1,865 · see citing works

Molecular Basis for Feedback Regulation of Bile Acid Synthesis by Nuclear Receptors

Lu, T. T., Makishima, M., Repa, J. J., Schoonjans, K., Kerr, T. A., Auwerx, J., & Mangelsdorf, D. J. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00050-2 · Cited by 1,487 · see citing works

Primary Biliary Cirrhosis

Schwab, M. (2011) · Springer eBooks · doi:10.1007/978-3-642-16483-5_4730 · Cited by 1,241 · see citing works

Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor

Inagaki, T., Moschetta, A., Lee, Y.-K., Peng, L., Zhao, G., Downes, M., Yu, R. T., Shelton, J. M., Richardson, J. A., Repa, J. J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509592103 · Cited by 1,164 · see citing works

A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis

Nevens, F., Andreone, P., Mazzella, G., Strasser, S. I., Bowlus, C., Invernizzi, P., Drenth, J. P. H., Pockros, P. J., Regula, J., Beuers, U., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1509840 · Cited by 1,131 · see citing works

Primary biliary cirrhosis # †

Lindor, K. D., Gershwin, E. M., Poupon, R., Kaplan, M., Bergasa, N. V., & Heathcote, J. E. (2009) · Hepatology · doi:10.1002/hep.22906 · Cited by 1,099 · see citing works

Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome

Jones, B. V., Begley, M., Hill, C., Gahan, C. G. M., & Marchesi, J. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804437105 · Cited by 1,098 · see citing works

Modulation of the fecal bile acid profile by gut microbiota in cirrhosis

Kakiyama, G., Pandak, W. M., Gillevet, P. M., Hylemon, P. B., Heuman, D. M., Daita, K., Takei, H., Muto, A., Nittono, H., Ridlon, J. M., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.01.003 · Cited by 782 · see citing works

Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy

Chazouillères, O., Wendum, D., Serfaty, L., Montembault, S., Rosmorduc, O., & Poupon, R. (1998) · Hepatology · doi:10.1002/hep.510280203 · Cited by 746 · see citing works

Primary biliary cirrhosis

Carey, E. J., Ali, A. H., & Lindor, K. D. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00154-3 · Cited by 735 · see citing works

Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesisPreprint

Holt, J. A., Luo, G., Billin, A. N., Bisi, J., McNeill, Y. Y., Kozarsky, K., Donahee, M. H., Wang, D. Y., Mansfield, T. A., Kliewer, S. A., et al. (2003) · Genes & Development · doi:10.1101/gad.1083503 · Cited by 698 · see citing works

Using QIIME to Analyze 16S rRNA Gene Sequences from Microbial Communities

Kuczynski, J., Stombaugh, J., Walters, W. A., González, A., Caporaso, J. G., & Knight, R. D. (2012) · Current Protocols in Microbiology · doi:10.1002/9780471729259.mc01e05s27 · Cited by 661 · see citing works

Molecular mimicry and autoimmunity

Rojas, M., Restrepo-Jiménez, P., Monsalve, D. M., Pacheco, Y., Acosta-Ampudia, Y., Ramírez-Santana, C., Leung, P. S. C., Ansari, A. A., Gershwin, M. E., & Anaya, J.-M. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.10.012 · Cited by 627 · see citing works

[Primary biliary cirrhosis].

Celaya, F. B. (1989) · PubMed · Cited by 504 · see citing works

Early primary biliary cirrhosis: Biochemical response to treatment and prediction of long-term outcome

Corpechot, C., Chazouillères, O., & Poupon, R. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.02.031 · Cited by 460 · see citing works

Role of bile acids in metabolic control

Molinaro, A., Wahlström, A., & Marschall, H.-U. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2017.11.002 · Cited by 447 · see citing works

Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy

Tang, R., Wei, Y., Li, Y., Chen, W., Chen, H., Wang, Q., Yang, F., Miao, Q., Xiao, X., Zhang, H., et al. (2018) · Gut · doi:10.1136/gutjnl-2016-313332 · Cited by 434 · see citing works

The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids

Puri, P., Daita, K., Joyce, A., Mirshahi, F., Santhekadur, P. K., Cazanave, S., Luketic, V. A., Siddiqui, M. S., Boyett, S., Min, H., et al. (2018) · Hepatology · doi:10.1002/hep.29359 · Cited by 426 · see citing works

A biliary HCO3- umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes

Hohenester, S., de Buy Wenniger, L. M., Paulusma, C. C., van Vliet, S. J., Jefferson, D. M., Oude Elferink, R. P., & Beuers, U. (2012) · Hepatology · doi:10.1002/hep.24691 · Cited by 315 · see citing works

Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity

Mueller, M., Thorell, A., Claudel, T., Jha, P., Köfeler, H. C., Lackner, C., Hoesel, B., Fauler, G., Stojaković, T., Einarsson, C., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.034 · Cited by 314 · see citing works

The ascending pathophysiology of cholestatic liver disease

Jansen, P. L. M., Ghallab, A., Vartak, N., Reif, R., Schaap, F. G., Hampe, J., & Hengstler, J. G. (2017) · Hepatology · doi:10.1002/hep.28965 · Cited by 301 · see citing works

A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis

Kowdley, K. V., Luketic, V., Chapman, R., Hirschfield, G. M., Poupon, R., Schramm, C., Vincent, C., Rust, C., Parés, A., Mason, A., et al. (2018) · Hepatology · doi:10.1002/hep.29569 · Cited by 281 · see citing works

High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis #

Schaap, F. G., Gaag, N. A. V. D., Gouma, D. J., & Jansen, P. L. M. (2008) · Hepatology · doi:10.1002/hep.22771 · Cited by 279 · see citing works

Mechanisms of bile acid mediated inflammation in the liver

Li, M., Cai, S., & Boyer, J. L. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.06.001 · Cited by 268 · see citing works

Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases

Li, Y., Tang, R., Leung, P. S. C., Gershwin, M. E., & Ma, X. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.07.002 · Cited by 247 · see citing works

Alterations and correlations of the gut microbiome, metabolism and immunity in patients with primary biliary cirrhosis

Lv, L., Fang, D., Shi, D., Chen, D., Yan, R., Zhu, Y., Chen, Y., Shao, L., Guo, F., Wu, W., et al. (2016) · Environmental Microbiology · doi:10.1111/1462-2920.13401 · Cited by 245 · see citing works

Bile acid modifications at the microbe-host interface: potential for nutraceutical and pharmaceutical interventions in host health

Joyce, S. A., & Gahan, C. G. M. (2016) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-041715-033159 · Cited by 241 · see citing works

The role of sphingosine 1‐phosphate receptor 2 in bile‐acid–induced cholangiocyte proliferation and cholestasis‐induced liver injury in mice

Wang, Y., Aoki, H., Yang, J., Peng, K., Liu, R., Li, X., Qiang, X., Sun, L., Gurley, E. C., Lai, G., et al. (2017) · Hepatology · doi:10.1002/hep.29076 · Cited by 241 · see citing works

New therapeutic concepts in bile acid transport and signaling for management of cholestasis

Trauner, M., Fuchs, C. D., Halilbasic, E., & Paumgartner, G. (2017) · Hepatology · doi:10.1002/hep.28991 · Cited by 227 · see citing works

Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis

Tabibian, J. H., O'Hara, S. P., Trussoni, C. E., Tietz, P. S., Splinter, P. L., Mounajjed, T., Hagey, L. R., & LaRusso, N. F. (2016) · Hepatology · doi:10.1002/hep.27927 · Cited by 223 · see citing works

Biliary bile acids in hepatobiliary injury – What is the link?

Fickert, P., & Wagner, M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.04.026 · Cited by 187 · see citing works

Taurine reduction in anaerobic respiration of Bilophila wadsworthia RZATAU

Laue, H., Denger, K., & Cook, A. M. (1997) · Applied and Environmental Microbiology · doi:10.1128/aem.63.5.2016-2021.1997 · Cited by 169 · see citing works

Prognosis of ursodeoxycholic Acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients

ter Borg, P. C. J., Schalm, S. W., Hansen, B. E., & van Buuren, H. R. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00699.x · Cited by 160 · see citing works

Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: A pilot study

Trottier, J., Bialek, A. P., Caron, P., Straka, R. J., Heathcote, J., Milkiewicz, P., & Barbier, O. (2011) · Digestive and Liver Disease · doi:10.1016/j.dld.2011.10.025 · Cited by 157 · see citing works

The bilateral responsiveness between intestinal microbes and IgA

Macpherson, A. J., Köller, Y., & McCoy, K. D. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.06.006 · Cited by 151 · see citing works

Fasting Serum Taurine-Conjugated Bile Acids Are Elevated in Type 2 Diabetes and Do Not Change With Intensification of Insulin

Wewalka, M., Patti, M., Barbato, C., Houten, S. M., & Goldfine, A. B. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3367 · Cited by 130 · see citing works

Early biochemical response to ursodeoxycholic acid and long-term prognosis of primary biliary cirrhosis: Results of a 14-year cohort study

Zhang, L.-N., Shi, T.-Y., Shi, X.-H., Wang, L., Yang, Y.-J., Liu, B., Gao, L.-X., Shuai, Z.-W., Kong, F., Chen, H., et al. (2013) · Hepatology · doi:10.1002/hep.26322 · Cited by 113 · see citing works

Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health

Dilger, K., Hohenester, S. D., Winkler–Budenhofer, U., Bastiaansen, B. A. J., Schaap, F. G., Rust, C., & Beuers, U. H. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.014 · Cited by 112 · see citing works

Bile Acids Metabonomic Study on the CCl4- and α-Naphthylisothiocyanate-Induced Animal Models: Quantitative Analysis of 22 Bile Acids by Ultraperformance Liquid Chromatography−Mass Spectrometry

Yang, L., Xiong, A., He, Y., Wang, Z., Wang, C., Wang, Z., Li, W., Yang, L., & Zhi-bi, H. (2008) · Chemical Research in Toxicology · doi:10.1021/tx800225q · Cited by 104 · see citing works

Expression of hepatic Fibroblast Growth Factor 19 is enhanced in Primary Biliary Cirrhosis and correlates with severity of the disease

Wunsch, E., Milkiewicz, M., Wasik, U., Trottier, J., Kempińska‐Podhorodecka, A., Elias, E., Barbier, O., & Milkiewicz, P. (2015) · Scientific Reports · doi:10.1038/srep13462 · Cited by 97 · see citing works

Serum metabolic signatures of primary biliary cirrhosis and primary sclerosing cholangitis

Bell, L. N., Wulff, J. E., Comerford, M., Vuppalanchi, R., & Chalasani, N. (2014) · Liver International · doi:10.1111/liv.12680 · Cited by 83 · see citing works

Host-microbiota interactions and adaptive immunity

McCoy, K. D., Ronchi, F., & Geuking, M. B. (2017) · Immunological Reviews · doi:10.1111/imr.12575 · Cited by 77 · see citing works

Gut microbiota translocation promotes autoimmune cholangitis

Ma, H.-D., Zhao, Z.-B., Ma, W.-T., Liu, Q.-Z., Gao, C., Li, L., Wang, J., Tsuneyama, K., Liu, B., Zhang, W., et al. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.09.010 · Cited by 73 · see citing works

Circulating FGF19 closely correlates with bile acid synthesis and cholestasis in patients with primary biliary cirrhosis

Li, Z.-Y., Lin, B., Lin, G., Wu, Y.-K., Jie, Y., Li, X.-Y., Ko, B., Chong, Y., & Luo, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178580 · Cited by 59 · see citing works

Old and new treatments for primary biliary cholangitis

Chascsa, D. M. H., Carey, E. J., & Lindor, K. D. (2017) · Liver International · doi:10.1111/liv.13294 · Cited by 50 · see citing works

The immunobiology of female predominance in primary biliary cholangitis

Gerussi, A., Cristoferi, L., Carbone, M., Asselta, R., & Invernizzi, P. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.10.015 · Cited by 41 · see citing works

Urine and serum metabolomic profiling reveals that bile acids and carnitine may be potential biomarkers of primary biliary cirrhosis

Tang, Y., Wang, J.-P., BAO, W.-M., Yang, J., Ma, L., Yang, J., CHEN, H., Xu, Y., Yang, L., Li, W., et al. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2233 · Cited by 39 · see citing works

Primary biliary cirrhosis and bile acids

Corpechot, C. (2012) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/s2210-7401(12)70016-5 · Cited by 27 · see citing works

Gut microbiome, liver immunology, and liver diseases

Wang, R., Tang, R., Li, B., Ma, X., Schnabl, B., & Tilg, H. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00592-6 · Cited by 466 · see citing works

Primary biliary cholangitis.

Tanaka, A., Ma, X., Takahashi, A., & Vierling, J. M. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01303-5 · Cited by 177 · see citing works

Ursodeoxycholic acid and cancer: From chemoprevention to chemotherapy

Goossens, J., & Bailly, C. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107396 · Cited by 155 · see citing works

Gardenia jasminoides Ellis polysaccharide ameliorates cholestatic liver injury by alleviating gut microbiota dysbiosis and inhibiting the TLR4/NF-κB signaling pathway

Fang, S., Wang, T., Li, Y., Xue, H., Zou, J., Cai, J., Shi, R., Wu, J., & Ma, Y. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.02.056 · Cited by 135 · see citing works

The microbiota and the gut–liver axis in primary sclerosing cholangitis

Hov, J. R., & Karlsen, T. H. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00690-y · Cited by 121 · see citing works

From dried bear bile to molecular investigation: A systematic review of the effect of bile acids on cell apoptosis, oxidative stress and inflammation in the brain, across pre-clinical models of neurological, neurodegenerative and neuropsychiatric disorders

Huang, F., Pariante, C. M., & Borsini, A. (2022) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.09.021 · Cited by 117 · see citing works

The challenges of primary biliary cholangitis: What is new and what needs to be done

Terziroli Beretta-Piccoli, B., Mieli-Vergani, G., Vergani, D., Vierling, J. M., Adams, D., Alpini, G., Banales, J. M., Beuers, U., Björnsson, E., Bowlus, C., et al. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102328 · Cited by 114 · see citing works

The Gut-Liver Axis in Cholestatic Liver Diseases

Blesl, A., & Stadlbauer, V. (2021) · Nutrients · doi:10.3390/nu13031018 · Cited by 99 · see citing works

A Current Understanding of Bile Acids in Chronic Liver Disease

Farooqui, N., Elhence, A., & Shalimar, S. (2021) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2021.08.017 · Cited by 91 · see citing works

Microbiota diversity in nonalcoholic fatty liver disease and in drug-induced liver injury

Rodriguez, C., Taminiau, B., García-García, A., Cueto‐Sánchez, A., Robles‐Díaz, M., Ortega‐Alonso, A., Martín‐Reyes, F., Daube, G., Sanabria‐Cabrera, J., Pérez, M. J., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106348 · Cited by 91 · see citing works

The Role of Gut Microbiota in Some Liver Diseases: From an Immunological Perspective

Wang, L., Cao, Z.-M., Zhang, L., Li, J.-M., & Lv, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.923599 · Cited by 87 · see citing works

Gut microbiome determines therapeutic effects of OCA on NAFLD by modulating bile acid metabolism

Liu, J., Sun, J., Yu, J., Chen, H., Zhang, D., Zhang, T., Ma, Y., Zou, C., Zhang, Z., Ma, L., et al. (2023) · npj Biofilms and Microbiomes · doi:10.1038/s41522-023-00399-z · Cited by 82 · see citing works

Associations between Dietary Patterns and Bile Acids—Results from a Cross-Sectional Study in Vegans and Omnivores

Trefflich, I., Marschall, H., di Giuseppe, R., Ståhlman, M., Michalsen, A., Lampen, A., Abraham, K., & Weikert, C. (2019) · Nutrients · doi:10.3390/nu12010047 · Cited by 78 · see citing works

Chronic lead exposure induces fatty liver disease associated with the variations of gut microbiota

Wan, H., Wang, Y., Zhang, H., Zhang, K., Chen, Y., Chen, C., Zhang, W., Xia, F., Wang, N., & Lu, Y. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.113257 · Cited by 77 · see citing works

Bile Acid Signaling in Metabolic and Inflammatory Diseases and Drug Development

Li, T., & Chiang, J. Y. L. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.124.000978 · Cited by 83 · see citing works

Alterations in microbiota and their metabolites are associated with beneficial effects of bile acid sequestrant on icteric primary biliary Cholangitis

Li, B., Zhang, J., Chen, Y., Wang, Q., Li, Y., Wang, R., Wei, Y., You, Z., Li, Y., Miao, Q., et al. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1946366 · Cited by 74 · see citing works

The gut microbiota–bile acid axis: A potential therapeutic target for liver fibrosis

Zhang, Y., Li, Z.-J., Gou, H.-Z., Song, X., & Zhang, L. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.945368 · Cited by 74 · see citing works

Apple Polyphenol Extract Improves High-Fat Diet-Induced Hepatic Steatosis by Regulating Bile Acid Synthesis and Gut Microbiota in C57BL/6 Male Mice

Li, D., Cui, Y., Wang, X., Liu, F., & Li, X. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c02532 · Cited by 72 · see citing works

Cholangiopathy and Biliary Fibrosis in Cyp2c70-Deficient Mice Are Fully Reversed by Ursodeoxycholic Acid

de Boer, J. F., de Vries, H. D., Palmiotti, A., Li, R., Doestzada, M., Hoogerland, J. A., Fu, J., Rose, A. M. L., Westerterp, M., Mulder, N. L., et al. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.12.004 · Cited by 68 · see citing works

Effects of Icariin on Modulating Gut Microbiota and Regulating Metabolite Alterations to Prevent Bone Loss in Ovariectomized Rat Model

Wang, S.-S., Wang, S., Wang, X., Xu, Y., Zhang, X., Han, Y., Yan, H., Liu, L., Wang, L., Ye, H., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.874849 · Cited by 63 · see citing works

Fibrotic Events in the Progression of Cholestatic Liver Disease

Wu, H., Chen, C., Ziani, S., Nelson, L. J., Avila, M. A., Nevzorova, Y. A., & Cubero, F. J. (2021) · Cells · doi:10.3390/cells10051107 · Cited by 59 · see citing works

The intestinal and biliary microbiome in autoimmune liver disease—current evidence and concepts

Liwinski, T., Heinemann, M., & Schramm, C. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00936-6 · Cited by 59 · see citing works

The Effects of Androgens on T Cells: Clues to Female Predominance in Autoimmune Liver Diseases?

Henze, L., Schwinge, D., & Schramm, C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01567 · Cited by 58 · see citing works

Bile Acids, Liver Cirrhosis, and Extrahepatic Vascular Dysfunction

Sauerbruch, T., Hennenberg, M., Trebicka, J., & Beuers, U. H. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.718783 · Cited by 51 · see citing works

Bile acids as regulatory molecules and potential targets in metabolic diseases

Xie, A.-J., Mai, C.-T., Zhu, Y. Z., Liu, X., & Xie, Y. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120152 · Cited by 51 · see citing works

Biliary Diseases from the Microbiome Perspective: How Microorganisms Could Change the Approach to Benign and Malignant Diseases

Binda, C., Gibiino, G., Coluccio, C., Sbrancia, M., Dajti, E., Sinagra, E., Capurso, G., Sambri, V., Cucchetti, A., Ercolani, G., et al. (2022) · Microorganisms · doi:10.3390/microorganisms10020312 · Cited by 52 · see citing works

Ileal mucosa-associated microbiota overgrowth associated with pathogenesis of primary biliary cholangitis

Kitahata, S., Yamamoto, Y., Yoshida, O., Tokumoto, Y., Kawamura, T., Furukawa, S., Kumagi, T., Hirooka, M., Takeshita, E., Abe, M., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-99314-9 · Cited by 47 · see citing works

The Role of B Cells and B Cell Therapies in Immune-Mediated Liver Diseases

Cargill, T., & Culver, E. L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.661196 · Cited by 46 · see citing works

Changes of Gut-Microbiota-Liver Axis in Hepatitis C Virus Infection

El‐Mowafy, M., Elgaml, A., El‐Mesery, M., Sultan, S., Ahmed, T. A., Gomaa, A. I., Aly, M., & Mottawea, W. (2021) · Biology · doi:10.3390/biology10010055 · Cited by 47 · see citing works

The Potential of Bile Acids as Biomarkers for Metabolic Disorders

Yin, C., Zhong, R., Zhang, W., Liu, L., Chen, L., & Zhang, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512123 · Cited by 45 · see citing works

Intrahepatic cholestasis induced by α-naphthylisothiocyanate can cause gut-liver axis disorders

Chen, Z., Wu, Y., Wang, B., Fang, J., Gan, C., Sang, C., Dun, Z., Luosang, T., Wang, Q., Zeren, D., et al. (2021) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2021.103672 · Cited by 40 · see citing works

Alterations in gut microbiota and elevated serum bilirubin in primary biliary cholangitis patients treated with ursodeoxycholic acid

Han, W., Huang, C., Zhang, Q., Tao, S., Hu, X., Xu, J., Jiang, R., Xu, B., Liu, Y., & Hou, J. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13714 · Cited by 40 · see citing works

Crosstalk between Gut Microbiota and Bile Acids in Cholestatic Liver Disease

Shi, Q., Yuan, X., Zeng, Y., Wang, J., Zhang, Y., Chen, X., & Li, L. (2023) · Nutrients · doi:10.3390/nu15102411 · Cited by 41 · see citing works

Multi-omics: Differential expression of IFN-γ results in distinctive mechanistic features linking chronic inflammation, gut dysbiosis, and autoimmune diseases

Bae, H. R., Leung, P. S. C., Hodge, D. L., Fenimore, J. M., Jeon, S.-M., Thovarai, V., Dzutsev, A., Welcher, A. A., Boedigheimer, M. J., Damore, M. A., et al. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102436 · Cited by 39 · see citing works

Primary biliary cholangitis: molecular pathogenesis perspectives and therapeutic potential of natural products

Zhao, Y., Wei, S., Chen, L., Zhou, X., & Ma, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1164202 · Cited by 38 · see citing works

Short-chain fatty acid and fecal microbiota profiles are linked to fibrosis in primary biliary cholangitis

Lammert, C. S., Shin, A., Xu, H., Hemmerich, C. M., O’Connell, T. M., & Chalasani, N. (2021) · FEMS Microbiology Letters · doi:10.1093/femsle/fnab038 · Cited by 36 · see citing works

Gut-Liver Immune Traffic: Deciphering Immune-Pathogenesis to Underpin Translational Therapy

Bozward, A. G., Ronca, V., Osei‐Bordom, D., & Oo, Y. H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.711217 · Cited by 36 · see citing works

Role of microbiome in autoimmune liver diseases

Schneider, K. M., Kummen, M., Trivedi, P. J., & Hov, J. R. (2023) · Hepatology · doi:10.1097/hep.0000000000000506 · Cited by 35 · see citing works

Targeting bile acid signaling for the treatment of liver diseases: From bench to bed

Duan, S., Li, X., Fan, G., & Liu, R. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113154 · Cited by 33 · see citing works

Bacterial and metabolic phenotypes associated with inadequate response to ursodeoxycholic acid treatment in primary biliary cholangitis

Martinez-Gili, L., Pechlivanis, A., McDonald, J. A. K., Begum, S., Badrock, J., Dyson, J. K., Jones, R., Hirschfield, G., Ryder, S. D., Sandford, R., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2208501 · Cited by 32 · see citing works

Fecal Microbiota Transplantation in Patients with HBV Infection or Other Chronic Liver Diseases: Update on Current Knowledge and Future Perspectives

Paratore, M., Santopaolo, F., Cammarota, G., Pompili, M., Gasbarrini, A., & Ponziani, F. R. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10122605 · Cited by 30 · see citing works

Association between circulating bile acid alterations and nonalcoholic steatohepatitis independent of obesity and diabetes mellitus

Jung, Y., Koo, B. K., Jang, S. Y., Kim, D. R., Lee, H., Lee, D. H., Joo, S. K., Jung, Y. J., Park, J. H., Yoo, T., et al. (2021) · Liver International · doi:10.1111/liv.15030 · Cited by 30 · see citing works

Exploring Advanced Therapies for Primary Biliary Cholangitis: Insights from the Gut Microbiota–Bile Acid–Immunity Network

Guo, Z., He, K., Pang, K., Yang, D., Lyu, C., Xu, H., & Wu, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084321 · Cited by 29 · see citing works

Artemisia capillaris Thunb. Polysaccharide alleviates cholestatic liver injury through gut microbiota modulation and Nrf2 signaling pathway activation in mice

Cai, J., Zhu, Z., Li, Y., Li, Q., Tian, T., Meng, Q., Wang, T., Ma, Y., & Wu, J. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118009 · Cited by 28 · see citing works

The Microbiome in Autoimmune Liver Diseases: Metagenomic and Metabolomic Changes

Zheng, Y., Ran, Y., Zhang, H., Wang, B., & Zhou, L. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.715852 · Cited by 28 · see citing works

Genetic predisposition of the gastrointestinal microbiome and primary biliary cholangitis: a bi-directional, two-sample Mendelian randomization analysis

Luo, X., & You, X. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1225742 · Cited by 26 · see citing works

Loss of SLC27A5 Activates Hepatic Stellate Cells and Promotes Liver Fibrosis via Unconjugated Cholic Acid

Wu, K., Liu, Y., Xia, J. L., Liu, J., Wang, K., Liang, H., Xu, F., Liu, D., Nie, D., Tang, X., et al. (2023) · Advanced Science · doi:10.1002/advs.202304408 · Cited by 27 · see citing works

Microbiota and viral hepatitis: State of the art of a complex matter

Milošević, I., Russo, E., Vujović, A., Barac, A. M., Stevanović, O., Gitto, S., & Amedei, A. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i33.5488 · Cited by 28 · see citing works

Intestinal microbiota and biliary system diseases

Wang, H., Gong, J., Chen, J., Zhang, W., Sun, Y., & Sun, D. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1362933 · Cited by 26 · see citing works

Hepatic Autophagy Deficiency Remodels Gut Microbiota for Adaptive Protection via FGF15-FGFR4 Signaling

Yan, S., Khambu, B., Chen, X., Dong, Z., Guo, G. L., & Yin, X. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.10.011 · Cited by 26 · see citing works

Current Landscape and Evolving Therapies for Primary Biliary Cholangitis

Fiorucci, S., Urbani, G., Giorgio, C. D., Biagioli, M., & Distrutti, E. (2024) · Cells · doi:10.3390/cells13181580 · Cited by 28 · see citing works

Changes in the gut microbiota of mice orally exposed to methylimidazolium ionic liquids

Young, G. R., Abdelghany, T. M., Leitch, A. C., Dunn, M. P., Blain, P. G., Lanyon, C. V., & Wright, M. C. (2020) · PLoS ONE · doi:10.1371/journal.pone.0229745 · Cited by 25 · see citing works

Bile Acids and Biliary Fibrosis

Aseem, S. O., Hylemon, P. B., & Zhou, H. (2023) · Cells · doi:10.3390/cells12050792 · Cited by 24 · see citing works

Immunologic Responses and the Pathophysiology of Primary Biliary Cholangitis

Chen, R., Tang, R., Ma, X., & Gershwin, M. E. (2022) · Clinics in Liver Disease · doi:10.1016/j.cld.2022.06.003 · Cited by 24 · see citing works

Targeting Gut Microbiota for the Treatment of Primary Biliary Cholangitis: From Bench to Bedside

Zhang, L., Yang, L., & Chu, H. (2023) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2022.00408 · Cited by 24 · see citing works

Effect of type of dietary non‐protein energy source (starch vs. fat) on the body bile acid pool size and composition, faecal bile acid loss and bile acid synthesis in rainbow trout ( Oncorhynchus mykiss )

Staessen, T. W. O., Verdegem, M. C. J., Nederlof, M. A. J., Eding, E. H., & Schrama, J. W. (2021) · Aquaculture Nutrition · doi:10.1111/anu.13231 · Cited by 22 · see citing works

The Role of the Microbiota Gut–Liver Axis during HCV Chronic Infection: A Schematic Overview

Marascio, N., Caro, C. D., Quirino, A., Mazzitelli, M., Russo, E., Torti, C., & Matera, G. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11195936 · Cited by 22 · see citing works

The Salivary Microbiota of Patients With Primary Biliary Cholangitis Is Distinctive and Pathogenic

Lv, L., Jiang, H., Chen, X., Wang, Q., Wang, K., Ye, J., Li, Y., Fang, D., Lu, Y., Yang, L., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.713647 · Cited by 22 · see citing works

The bile acid profile

Liu, Z., & You, C. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.120004 · Cited by 21 · see citing works

The Relationship Between Gut Microbiome and Bile Acids in Primates With Diverse Diets

Li, X., Wang, X., Wang, Z., Zhang, M., Wang, S., Xiang, Z., Pan, H., & Li, M. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.899102 · Cited by 21 · see citing works

Bile Acids: Physiological Activity and Perspectives of Using in Clinical and Laboratory Diagnostics

Shansky, Y. D., & Bespyatykh, J. (2022) · Molecules · doi:10.3390/molecules27227830 · Cited by 21 · see citing works

Gut Microbiome in a Russian Cohort of Pre- and Post-Cholecystectomy Female Patients

Григорьева, И. Н., Romanova, T., Naumova, N., Alikina, T. Y., Kuznetsov, A. V., & Kabilov, M. R. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11040294 · Cited by 20 · see citing works

Gut microbiome and liver diseases

Xu, J., Chen, N., Zhou, L., & Liu, Y. (2024) · Fundamental Research · doi:10.1016/j.fmre.2024.09.007 · Cited by 19 · see citing works

Bile acids as metabolic regulators: an update

Li, T., & Chiang, J. Y. L. (2023) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000934 · Cited by 19 · see citing works

Accumulation of altered serum bile acids predicts liver injury after portoenterostomy in biliary atresia

Nyholm, I., Hukkinen, M., Lohi, J., Sjöblom, N., Mutka, A., Mutanen, A., Ruuska, S., Neuvonen, M., Hänninen, S. M., Carpén, O., et al. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.01.025 · Cited by 18 · see citing works

Combining ASBT inhibitor and FGF15 treatments enhances therapeutic efficacy against cholangiopathy in female but not male Cyp2c70 KO mice

Hasan, M. N., Chen, J., Matye, D. J., Wang, H., Luo, W., Gu, L., Clayton, Y. D., Du, Y., & Li, T. (2023) · Journal of Lipid Research · doi:10.1016/j.jlr.2023.100340 · Cited by 18 · see citing works

Ursodeoxycholic acid impairs liver‐infiltrating T‐cell chemotaxis through IFN‐γ and CX3CL1 production in primary biliary cholangitis

Shimoyama, S., Kawata, K., Ohta, K., Chida, T., Suzuki, T., Tsuneyama, K., Shimoda, S., Kurono, N., Leung, P. S. C., Gershwin, M. E., et al. (2021) · European Journal of Immunology · doi:10.1002/eji.202048589 · Cited by 18 · see citing works

Hyperoside modulates bile acid and fatty acid metabolism, presenting a potentially promising treatment for non-alcoholic fatty liver disease

Wang, S., Jia, Q., Liu, X., Ma, Y., Yang, Y., Rong, X., Wang, Y., Wang, H., Liu, F., Yang, S., et al. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.05.014 · Cited by 17 · see citing works

Beneficial effects of inorganic nitrate in non-alcoholic fatty liver disease

Liu, Y., Croft, K. D., Caparros-Martin, J. A., O’Gara, F., Mori, T. A., & Ward, N. C. (2021) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2021.109032 · Cited by 16 · see citing works

Substance P Hinders Bile Acid-Induced Hepatocellular Injury by Modulating Oxidative Stress and Inflammation

Lee, D., Park, J. S., Kim, D., & Hong, H. S. (2022) · Antioxidants · doi:10.3390/antiox11050920 · Cited by 16 · see citing works

Gut microbiome in liver pathophysiology and cholestatic liver disease

Yan, S., & Yin, X. (2021) · Liver Research · doi:10.1016/j.livres.2021.08.001 · Cited by 16 · see citing works

Suppression of the gut microbiota–bile acid– FGF19 axis in patients with atrial fibrillation

Zuo, K., Chen, F., Gao, Y., Fu, Y., Wang, H., Li, J., Zhong, J., Yang, X., & Xu, L. (2023) · Cell Proliferation · doi:10.1111/cpr.13488 · Cited by 15 · see citing works

Modulating gut microbiota in autoimmune diseases: a cutting-edge strategy from prophylaxis to therapeutics

Wang, M., Liu, Y., Zhao, L., & Zhang, X. (2021) · 中国科学通报：英文版 · doi:10.1016/j.scib.2021.12.021 · Cited by 15 · see citing works

Gut microbiome and bile acid metabolism in liver disease: Mechanisms, clinical implications, and therapeutic opportunities

Zhou, H., Huang, Y., Chen, C., Song, M., & Hylemon, P. B. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100120 · Cited by 15 · see citing works

Causal associations between gut microbiota and primary biliary cholangitis: a bidirectional two-sample Mendelian randomization study

Zhang, J., Wu, G., Tang, Y., Liu, H., Ge, X., Peng, R., Cao, J., Tu, D., Su, B., Jin, S., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1273024 · Cited by 13 · see citing works

Taurine-conjugated bile acids and their link to hepatic S1PR2 play a significant role in hepatitis C–related liver disease

Ali, R., Haddad, J. A., Quinn, G. M., Zhang, G. Y., Townsend, E. C., Scheuing, L., Hill, K. L., Menkart, M. G., Oringher, J. L., Umarova, R., et al. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000478 · Cited by 13 · see citing works

Disease predisposition of human leukocyte antigen class II genes influences the gut microbiota composition in patients with primary biliary cholangitis

Huang, C., Zhang, H., Han, W., Zhao, D., Liao, H.-Y., Yin-xue, M., Xu, B., Li, L., Han, Y., Liu, X., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.984697 · Cited by 13 · see citing works

Intestinal homeostasis in autoimmune liver diseases

Liu, Q., He, W., Tang, R., & Ma, X. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002291 · Cited by 13 · see citing works

Breach of tolerance versus burden of bile acids: Resolving the conundrum in the immunopathogenesis and natural history of primary biliary cholangitis

Yamashita, M., Honda, A., Shimoyama, S., Umemura, M., Ohta, K., Chida, T., Noritake, H., Kurono, N., Ichimura‐Shimizu, M., Tsuneyama, K., et al. (2023) · Journal of Autoimmunity · doi:10.1016/j.jaut.2023.103027 · Cited by 13 · see citing works

Role of miR-506 in ulcerative colitis associated with primary sclerosing cholangitis

Kempińska‐Podhorodecka, A., Adamowicz, M., Ostrycharz, E., Chmielarz, M., Wójcicki, M., Milkiewicz, P., & Milkiewicz, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-89631-4 · Cited by 13 · see citing works

Hepatic Vps33b deficiency aggravates cholic acid-induced cholestatic liver injury in male mice

Fu, K., Chen, P., Zhou, Y., Jiang, Y., Gao, Y., Zhang, H., Guan, L., Wang, C., Liu, J., Huang, M., et al. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00723-3 · Cited by 13 · see citing works

Distinct signatures of gut microbiota and metabolites in primary biliary cholangitis with poor biochemical response after ursodeoxycholic acid treatment

Han, W., Song, T., Zhongyi, H., Liu, Y., Xu, B., & Huang, C. (2024) · Cell & Bioscience · doi:10.1186/s13578-024-01253-1 · Cited by 12 · see citing works

Gardenia jasminoides Ellis. Polysaccharides Alleviated Cholestatic Liver Injury by Increasing the Production of Butyric Acid and FXR Activation

Wang, T., Tian, T., Zhu, Z., Fang, S., Zhang, L., Peng, X., Shi, R., Li, Y., Wu, J.-S., & Ma, Y. (2024) · Phytotherapy Research · doi:10.1002/ptr.8326 · Cited by 11 · see citing works

Microbial Landscapes of the Gut–Biliary Axis: Implications for Benign and Malignant Biliary Tract Diseases

Meacci, D., Bruni, A., Cocquio, A., Dell’Anna, G., Mandarino, F. V., Marasco, G., Cecinato, P., Barbara, G., & Zagari, R. M. (2025) · Microorganisms · doi:10.3390/microorganisms13091980 · Cited by 11 · see citing works

Serum metabolic profiling of targeted bile acids reveals potentially novel biomarkers for primary biliary cholangitis and autoimmune hepatitis

Ma, Z., Wang, X., Wu, R., Hao, D.-L., Sun, L., Li, P., & Niu, J. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i39.5764 · Cited by 11 · see citing works

Primary Biliary Cholangitis: Immunopathogenesis and the Role of Bile Acid Metabolism in Disease Progression

Barrio, M. D., Díaz‐González, Á., & Alonso‐Peña, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26167905 · Cited by 10 · see citing works

Functional metabolomics characterizes the contribution of farnesoid X receptor in pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome

Xiong, A., Lu, L., Jiang, K., Wang, X., Chen, Y., Wang, X., Zhang, W., Zhuge, Y., Huang, W., Li, L., et al. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03762-x · Cited by 10 · see citing works

Gubra Amylin‐NASH Diet Induced Nonalcoholic Fatty Liver Disease Associated with Histological Damage, Oxidative Stress, Immune Disorders, Gut Microbiota, and Its Metabolic Dysbiosis in Colon

Zhang, Z., Qin, X., Yi, T., Li, Y., Li, C., Zeng, M., Luo, H., Lin, X., Xie, J., Xia, B., et al. (2024) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300845 · Cited by 10 · see citing works

Association of gut microbiota and gut metabolites and adverse outcomes in biliary atresia: A longitudinal prospective study

Jain, V., Dalby, M. J., Alexander, E. C., Burford, C., Acford-Palmer, H., Serghiou, I. R., Teng, N. M. Y., Kiu, R., Gerasimidis, K., Zafeiropoulou, K., et al. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000550 · Cited by 10 · see citing works

Immunobiology of bile and cholangiocytes

Yang, L., Leung, P. S. C., Zhang, W., Zhang, S., Liu, Z., Kurth, M. J., Patterson, A. D., Gershwin, M. E., & Song, J. (2025) · Journal of Autoimmunity · doi:10.1016/j.jaut.2025.103376 · Cited by 10 · see citing works

Gut Barrier, Microbial Metabolites, and Immune Homeostasis in Autoimmune Hepatitis: From Molecular Mechanisms to Strategies

Zhang, X., Wan, L., Zheng, Y., & Ai, Y. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl27747 · Cited by 10 · see citing works

Metabolic Profiling by UPLC–Orbitrap–MS/MS of Liver from C57BL/6 Mice with DSS-Induced Inflammatory Bowel Disease

Xin, Z., Zhai, Z., Long, H., Zhang, F., Ni, X., Deng, J., Yi, L., & Deng, B. (2020) · Mediators of Inflammation · doi:10.1155/2020/6020247 · Cited by 10 · see citing works

Gut Microbiota and Antibiotic Treatments for the Main Non-Oncologic Hepato-Biliary-Pancreatic Disorders

Vincenzo, F. D., Nicoletti, A., Negri, M., Vitale, F., Verme, L. Z. D., Gasbarrini, A., Ponziani, F. R., & Cerrito, L. (2023) · Antibiotics · doi:10.3390/antibiotics12061068 · Cited by 9 · see citing works

Relationship of Metabolic Dysfunction-Associated Steatohepatitis-Related Hepatocellular Carcinoma with Oral and Intestinal Microbiota: A Cross-Sectional Pilot Study

Matsui, T., Morozumi, T., Yamamoto, Y., Kobayashi, T., Takuma, R., Yoneda, M., Nogami, A., Kessoku, T., Tamura, M., Nomura, Y., et al. (2024) · Medicina · doi:10.3390/medicina60071150 · Cited by 9 · see citing works

Environmental Heat Stress Decreases Sperm Motility by Disrupting the Diurnal Rhythms of Rumen Microbes and Metabolites in Hu Rams

Wang, Q., Yi, H.-M., Ou, J.-Y., Wang, R., Wang, M.-M., Wang, P., He, X., Tang, W.-H., Chen, J., Yu, Y., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011161 · Cited by 9 · see citing works

Implications of gut microbiota in autoimmune liver diseases

Qian, Q., He, W., Tang, R., & Ma, X. (2021) · Minerva Gastroenterology · doi:10.23736/s2724-5985.21.02860-9 · Cited by 9 · see citing works

An Integrated Pathogenetic Model of Primary Biliary Cholangitis

Kouroumalis, E., Tsomidis, I., & Voumvouraki, A. (2025) · Livers · doi:10.3390/livers5020015 · Cited by 7 · see citing works

Targeting the gut microbiota and lipid metabolism: potential mechanisms of natural products for the treatment of non-alcoholic fatty liver disease

Zhang, Y., Wang, T., Han, J., Song, J., Yang, C., Liang, L., Li, H., & Wang, H. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1610498 · Cited by 7 · see citing works

Incomplete response to ursodeoxycholic acid in primary biliary cholangitis: criteria, epidemiology, and possible mechanisms

Huang, L., Wang, Z.-L., Jin, R., Chen, H.-S., & Feng, B. (2022) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2022.2153672 · Cited by 7 · see citing works

The gut microbiota: A new perspective for tertiary prevention of hepatobiliary and gallbladder diseases

Huang, X., Yang, Y., Li, X., Zhu, X., Lin, D., Ma, Y., Zhou, M., Cui, X., Zhang, B., Dang, D., et al. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1089909 · Cited by 7 · see citing works

Alterations in gut microbiota and elevated serum bilirubin in primary biliary cholangitis patients treated with ursodeoxycholic acid

Han, W., Huang, C., Zhang, Q., Tao, S., Hu, X., Xu, J., Jiang, R., Xu, B., Liu, Y., & Hou, J. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13714 · Cited by 40 · see citing works

Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy

Tang, R., Wei, Y., Li, Y., Chen, W., Chen, H., Wang, Q., Yang, F., Miao, Q., Xiao, X., Zhang, H., et al. (2018) · Gut · doi:10.1136/gutjnl-2016-313332 · Cited by 434 · see citing works

Unique bile acid profiles in the bile ducts of patients with primary sclerosing cholangitis

Kayashima, A., Sujino, T., Fukuhara, S., Miyamoto, K., Kubosawa, Y., Ichikawa, M., Kawasaki, S., Takabayashi, K., Iwasaki, E., Kato, M., et al. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000452 · Cited by 21 · see citing works

Therapeutic success in primary biliary cholangitis and gut microbiota: a safe highway?

Abenavoli, L., Scarlata, G. G. M., Scarpellini, E., Procopio, A. C., Ponziani, F. R., Boccuto, L., Ćetković, N. B., & Luzza, F. (2024) · Minerva Gastroenterology · doi:10.23736/s2724-5985.23.03590-8 · Cited by 5 · see citing works

Gut microbial profile of treatment-naive patients with primary biliary cholangitis

Zhou, Y.-J., Ying, G.-X., Dong, S.-L., Xiang, B., & Jin, Q.-F. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1126117 · Cited by 26 · see citing works